Radiopharm Theranostics Limited.
RADX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Radiopharm Theranostics Limited is a clinical-stage radiopharmaceutical company specializing in the development of innovative radiotheranostic products for the diagnosis and treatment of cancer. The company focuses on using targeted radiopharmaceuticals, which combine a targeting molecule with a rad...Show More
Better Health for All
-10
Radiopharm Theranostics' entire business is dedicated to developing radiopharmaceuticals for cancer diagnosis and treatment, with a pipeline of products in clinical trials.
1
One product, RAD 101, showed 92% of evaluable participants met the primary endpoint in a Phase 2b imaging study for brain metastases.
2
However, the company's products are investigational, and their safety and effectiveness have not been established or approved for sale in any country.
3
The company explicitly states it is not making investigational products available on an Expanded Access basis at this time.
4
Animal testing is a regulatory requirement, and the company uses novel molecular imaging technology to reduce animal use by 50% to 80%.
5
The company provides information for physicians and researchers to explore clinical trial collaborations and for individuals with cancer to learn about radiopharmaceuticals.
6
It has received ethics committee approvals for its Phase 1 clinical trials in Australia
7
and IND approval from the US FDA for a Phase 1 therapeutic study.
8
Fair Money & Economic Opportunity
0
Radiopharm Theranostics Limited is a clinical-stage radiopharmaceutical company focused on cancer diagnosis and treatment.
1
The company's core business does not involve lending, deposit, or other financial services to consumers.
2
As such, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed for financial institutions, are not applicable to RADX.US's operations, resulting in a score of 0 for each.
3
Fair Pay & Worker Respect
0
No specific, concrete data points for RADX.US were found in the provided articles for any of the Fair Pay & Worker Respect KPIs. One article discussed industry averages for CEO-to-median pay ratios for other pharmaceutical companies but provided no data for RADX.US.
1
Another article, mentioning 'Theranostics Health', explicitly stated that no quantitative data for the requested metrics was available.
2
The third article could not be accessed.
3
Fair Trade & Ethical Sourcing
0
No specific, concrete data points related to fair trade and ethical sourcing, such as fair-trade certification share, audit frequency, forced or child labor incidents, traceability coverage, remediation speed, ethical clause coverage, materials risk index, or supplier diversity spend, were found in the provided articles.
Honest & Fair Business
0
No evidence available to assess Radiopharm Theranostics Limited on Honest & Fair Business.
Kind to Animals
-50
Radiopharm Theranostics states that animal testing is a regulatory requirement, and they only conduct it in countries with the highest animal welfare standards (EU, USA, UK, Australia), where facilities are monitored by an impartial ethics committee or relevant authority.
1
This policy prohibits discretionary testing, as legal mandates still override alternatives. The company uses novel molecular imaging technology in animal studies, which enables a reduction in the number of animals used by 50% to 80%.
2
However, there is no explicit information about participation in multi-stakeholder initiatives to develop industry-wide animal-free testing and sourcing standards.
3
No War, No Weapons
0
Radiopharm Theranostics is a clinical-stage biopharmaceutical company focused on developing radiopharmaceuticals for cancer treatment
1
,
2
,
3
. The company's activities are strictly within the healthcare sector, specifically oncology, and there is no indication that their technology has dual-use potential that could be diverted for military purposes
4
,
5
,
6
. There is no evidence available in the provided articles to suggest any involvement in war, arms manufacturing, or conflict facilitation
7
,
8
,
9
. Therefore, based on the available information, a neutral score is appropriate.
Planet-Friendly Business
0
No evidence available to assess Radiopharm Theranostics Limited on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess Radiopharm Theranostics Limited on Respect for Cultures & Communities.
Safe & Smart Tech
0
No specific evidence was found in the provided articles regarding RADX.US's performance across any of the 'Safe & Smart Tech' KPIs. The articles discuss general industry challenges, regulatory requirements, and best practices in nuclear medicine and cybersecurity, but do not provide concrete data, actions, or policies attributable to RADX.US for any of the assessed metrics.
Zero Waste & Sustainable Products
0
No evidence available to assess Radiopharm Theranostics Limited on Zero Waste & Sustainable Products.